CHICAGO, April 8 (Reuters) - An experimental cancer drug made by Takeda Pharmaceutical Co (4502.T) showed signs of slowing tumors growth in mice and has advanced to early human trials, company researchers said on Wednesday.
CHICAGO, April 8 (Reuters) - An experimental cancer drug made by Takeda Pharmaceutical Co (4502.T) showed signs of slowing tumors growth in mice and has advanced to early human trials, company researchers said on Wednesday.
